Wie hoch ist der Preis für IAnthus Capital Holdings, Inc. (IAN)

Preis für IAnthus Capital Holdings, Inc. (IAN) ist $0.00366968

Wie hoch ist die Marktkapitalisierung für IAnthus Capital Holdings, Inc. (IAN)

Marktkapitalisierung für IAnthus Capital Holdings, Inc. (IAN) ist $25.59M

IAnthus Capital Holdings, Inc. (IAN) Gewinne

iAnthus Capital Holdings, Inc. is a U.S.-based cannabis enterprise that holds licenses for and actively manages cannabis cultivation, processing, and retail dispensary operations. Its diverse product portfolio encompasses both cannabis and cannabidiol (CBD) offerings. For cannabis, these include traditional biomass items like pre-rolls, various infused products such as edibles and topical creams, and a wide array of concentrates and vapeables, specifically live resins, waxes, oils, tinctures, and vape cartridges. The CBD line features topical creams, tinctures, and sprays, alongside a comprehensive range of beauty and skincare solutions, including lotions, haircare items, lip balms, and bath bombs. Beyond direct retail, the company also engages in wholesale distribution of its CBD product selection. Operationally, iAnthus maintains a significant presence, controlling or operating 32 retail dispensaries and 10 cultivation or processing facilities across eight states. Established in 2014, its corporate headquarters are located in New York, New York.

Jahr	Gewinn	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Gewinn

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Gewinn	Gewinnunterschied	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$1.76B	-	IN

Unternehmen

Gewinn

Gewinnunterschied

Land